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ABSTRACT
B cell subpopulations in the spleen have been extensively characterized phenotypically; however, biochemical properties of these 
cell populations following B cell antigen receptor engagement have not been fully determined due to technical difficulties and 
limiting cell numbers. We therefore employed mini-scale protocols to assess lipid signaling, particularly that of diacylglycerol and 
inositol trisphosphate, with as few as 0.5x106 purified early (T1) and late (T2) transitional B cells. Additionally, utilizing flow 
cytometric techniques, we determined levels of phosphatidylinositol bisphosphate and calcium mobilization in T1 and T2 cells, as 
well as mature follicular and marginal zone B cells using less than 1x106  primary B cells. Thus, these biochemical and flow 
cytometric  methodologies  can  be  used  to  analyse  signal-induced  changes  in  phosphatidylinositol  bisphosphate  levels, 
diacylglycerol and inositol triphosphate production and calcium in each B cell population.
INTRODUCTION
The B cell compartment within the mouse spleen is comprised 
of at least five subpopulations, including immature transitional 
type 1 (T1), transitional type 2 (T2) and T2-preMZ, as well as 
mature Follicular (Fo) and marginal zone (MZ) B cells (1-4). 
Signaling through the B cell antigen receptor (BCR) is required 
for the generation of a functional mature B cell repertoire (3, 5), 
and  multiple  components  of  the  BCR  signalosome  regulate 
biochemical events after BCR engagement. Upon activation by 
Btk,  PLC-γ2  catalyzes  the  hydrolysis  of  phosphatidylinositol 
bisphosphate (PtdInsP2 or PIP2) into the two second messengers, 
inositol trisphosphate (IP3), which activates Ca2+ signaling, and 
diacylglycerol (DAG), which activates  protein kinase C (PKC) 
signaling  pathways  (6,  7).  It  is  well  established  that  both 
calcium and PKC signaling are important in B cell survival and 
development/maturation, as  well  as  proliferation (8,  9).  Thus, 
quantities  of  PIP2,  DAG  and  IP3 are  likely  to  direct  the 
subsequent signaling events leading to the fate of developing B 
cells.  Developing  new  protocols  to  study  lipid  signaling  is 
therefore  a  prerequisite  for  understanding  the  molecular 
mechanisms underlying the generation of mature B cells. 
Because only a small number of each B cell subpopulation can 
be obtained by flow cytometry-based cell sorting methods, we 
developed and optimized mini-scale DAG and IP3 quantification 
protocols in order to analyze the levels of DAG and IP3 within 
transitional B cell subsets following BCR cross-linking. These 
protocols allowed the quantification of lipid species utilizing as 
few as 0.5-5x106 purified B cells.  Additionally,  utilizing flow 
cytometry (FCM) techniques to identify B cell populations, we 
analyzed PIP2 levels and calcium mobilization in transitional and 
mature B cell subsets, again using as few as 1x106 total B cells. 
Here we report  the detailed experimental procedure of micro-
scale flow cytometry and biochemical analysis of lipid signaling 
in primary B cells. 
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MATERIALS AND METHODS
Mice and B cell purification
Wild type C57BL/6 mice (Jackson Laboratories, Maine, USA) 
were used. All mice that were used as the source of splenocytes 
were  treated  humanely  in  accordance  with  federal  and  state 
government  guidelines  and  their  use  was  approved  by  the 
institutional animal committee.
Primary B  lymphocytes  were  isolated  from  single  cell 
suspensions  pooled  from the  spleens  of  C57BL/6  mice.  Cell 
suspensions were depleted of RBCs, and B lymphocytes were 
purified through magnetic sorting on an AutoMACS automated 
cell  sorter  (Miltenyi  Biotech)  by  negative  selection  (CD43-
depletion)  to  avoid  B  cell  activation.  The  purity  of  B  cells 
isolated in this manner was approximately 90–95% as verified 
by  FCM  analysis  using  anti-B220  and  anti-IgM  antibodies 
(Pharmingen,  USA).  FACS-sorting  for  highly  purified 
transitional  B  cell  subsets  was  performed  as  previously 
described (2).
Lipid analysis
PIP2 quantitation: PIP2 levels  following anti-IgM stimulation 
were  monitored  by  flow  cytometry.  MACS-enriched  B  cells 
were  resuspended  (10x106 cells/ml)  in  complete  RPMI-1640, 
rested on ice for 1.5 hours, and incubated for 15 minutes at 37°C 
prior to assay. Cells were then stimulated with 20 μg/ml goat 
anti-mouse IgM F(ab’)2 antibodies (Jackson ImmunoResearch) 
for  the  indicated  times,  and  immediately  fixed  (in  order  to 
preserve  PIP2 phosphorylation  status)  by  harvesting  100  μl 
(containing  1x106 cells)  into  1  ml  cold  PBS  +  2% 
paraformaldehyde at each time-point. Cells were permeabilized 
utilizing the Cytofix/Cytoperm kit (BD Biosciences) according 
to  the  manufacturer’s  instructions,  and  intracellularly  labeled 
with a biotinylated antibody raised against PI(4,5)P2 (Z-B045; 
Echelon Biosciences, Inc; 1:500 dilution) for 20 minutes on ice. 
Cells were then washed and labeled with APC-conjugated anti-
CD19 (clone 1D3; 1:100 dilution), FITC-conjugated anti-HSA 
(clone  M1/69;  1:500  dilution),  and  PE-conjugated  anti-CD21 
(clone 7G6, 1:400 dilution) for the identification of splenic B 
cell  subsets,  and  PerCP-Cy5.5-conjugated  streptavidin  (1:300 
dilution) to visualize PIP2. Anti-C1qRp (AA4.1) and anti-CD23 
antibodies were not utilized due to non-reactivity with B cells 
that have undergone fixation. Following a 20 minute incubation 
on ice,  cells  were washed,  and resuspended in  100 μl  FACS 
buffer  (2% FBS in PBS),  followed by 100 μl  fix  buffer  (2% 
paraformaldehyde in FACS buffer) to preserve the cells. To test 
the specificity of the anti-PIP2 antibody, freshly isolated MACS 
enriched  B  cells  were  fixed  and  permeabilized  as  described 
above,  then  intracellularly  labeled  with  an  anti-PIP2-FITC 
antibody (Z-G045;  Echelon  Biosciences,  Inc;  1:300  dilution) 
that had been pre-incubated with varying concentrations of PIP2 
liposomes (Y-P045 (biotinylated); Echelon Biosciences, Inc) for 
15 minutes on ice. Data was acquired on a BD FACSCalibur or 
BD LSRII flow cytometer. Results are expressed as MFI and are 
representative of multiple experiments. 
DAG  quantification: Purified  B  cells  were  labeled  with 
[3H]palmitic  acid  (2.5  mCi/ml),  as  a  fatty  acid  precursor. 
Labeled  B  cells  were  washed  twice  with  PBS,  incubated  for 
various time periods or stimulated through the BCR with goat 
anti-mouse IgM F(ab')2 as indicated. The reactions were stopped 
by the addition of excess cold PBS. The cells were pelleted by 
centrifugation  and  used  for  lipid  extraction.  The  pellet  was 
suspended in 2 ml chloroform-methanol (2:1 v/v) and 0.4 ml of 
0.5  N  HCl  was  added.  The  mixture  was  shaken  vigorously, 
centrifuged, and the upper (aqueous) phase was discarded while 
the lower (organic) washed twice with theoretical upper phase 
(10). The radioactivity of lipids was determined on an aliquot 
fraction  by  scintillation  counting.  Dipalmitin  carrier  standard 
was then added, the lipid phase evaporated gently under a N2 
stream  and  the  residue  dissolved  in  a  minimum  volume  of 
chloroform-methanol  (2:1  v/v).  DAG  was  separated  by  thin 
layer  chromatography  on  silica  gel  G  plates  using  a  double 
development system and detected under UV light after spraying 
the plates with primulin as previously described (11). The area 
containing DAG was scraped and the radioactivity determined 
as previously described (6, 11, 12).
[3H]-Inositol  labeled  soluble  inositol  polyphosphate  (IP)  
profiling: The soluble IP profile for B cells was determined by 
adapting a previously described protocol (13). Briefly, MACS-
enriched  total  B  cells  or  FACS-purified  B  cell  subsets 
(10x106/ml) were cultured in inositol-free DMEM containing 60 
mCi  [3H]Inositol/ml  (Perkin  Elmer)  for  4  hours.  Cells  were 
harvested, washed twice with 1 ml PBS and suspended in PBS 
(10x106/ml). 100 μl cell aliquots (containing 1x106 cells) were 
treated  with  25  μl  PBS with  or  without  20  μg/ml  goat  anti-
mouse IgM F(ab’)2. Treatments were stopped by adding 6.6 μl 
10 N HCl and chilling cells on ice. Soluble IPs were extracted 
by adding 465 μl of chloroform/methanol (1:2 v/v). The mixture 
was  vortexed  for  2  minutes  at  maximum speed,  followed by 
addition of 156 μl each of chloroform and 2 M KCl and another 
2 minutes of vortexing. The lysate was spun at 13,000 g for 5 
minutes and the supernatant recovered. Samples were analyzed 
by the HPLC (Shimadzu Corporation) connected to the Radio-
HPLC Detector (IN/US Systems, Inc.). The IPs were resolved 
by a Whatman partisphere SAX strong-anion exchange column 
(4.6 x 125 mm) and a linear gradient  from 10 mM to 1.7 M 
ammonium  phosphate  (pH  3.5)  for  25  minutes,  followed  by 
elution with 1.7 M ammonium phosphate for 20 minutes. 
Calcium mobilization in B cell subsets: MACS-enriched B cells 
were resuspended (10x106 cells/ml) in warm HBSS w/o phenol 
red,  and loaded with indo-1-AM (5 μg/ml) for  30 minutes at 
37°C. Cells were then washed, resuspended (20x106 cells/ml) in 
FACS buffer, placed on ice, and labeled for 20 minutes with PE-
conjugated anti-HSA (clone M1/69; 1:750 dilution), biotinylated 
anti-CD23 (clone B3B4; 1:200 dilution) which was visualized 
by PerCP-Cy5.5-conjugated  streptavidin  (1:200  dilution),  and 
APC-conjugated anti-C1qRp (clone AA4.1; 1:100 dilution) for 
B  cell  subset  identification.  Antibodies  raised  against  B220, 
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CD19, and/or CD21 were not used in order to avoid inadvertent 
stimulation of B cells. Following labeling, cells were washed, 
resuspended (1x106/ml) in HBSS containing 1 mM calcium, and 
kept on ice until assay. Prior to acquisition, cells were warmed 
for 15 minutes in a 37°C water bath, and applied to a BD LSR II 
cytometer.  Baseline,  non-stimulated measurements  were taken 
for 90 seconds, followed by the addition of 10 μg/ml goat anti-
mouse IgM F(ab’)2 antibodies for the indicated time. Ionomycin 
(1 mM) was used as a positive control to ensure that cells were 
competent to release calcium from intracellular stores. Data is 
expressed  as  a  ratio  of  Indo1-violet/Indo1-blue,  and  is  a 
representative of multiple experiments.
Statistics 
The  data  represent  the  mean  of  at  least  three  experiments 
analyzed utilizing Student's t-test.
RESULTS 
PIP2 hydrolysis occurs in all B cell subsets as determined 
by FCM 
Because PIP2 serves as a substrate for PLC-γ2 in the production 
of DAG (14), we wanted to determine basal and BCR-induced 
levels of PIP2 in all B cell subsets. MACS-enriched splenic B 
cells were stimulated, harvested, and immediately fixed in 2% 
paraformaldehyde  in  order  to  preserve  the  phosphorylation 
status of PIP2. Cells were then stained intracellular for PIP2 and 
extracellular with a combination of anti-HSA, anti-CD21, and 
anti-CD19 antibodies for B cell subset identification. Utilizing 
flow cytometric analysis, CD19+ cells were displayed with HSA 
and CD21 in order avoid inclusion of any remaining non-B cells 
in  the  analysis  (Fig.  1A).  CD21hi MZ  and  pre-MZ  were 
separated  based  on  differential  HSA  expression,  which 
corresponded to CD23 expression (preMZ are HSAhiCD23+, MZ 
are HSAmidCD23lo),  as we previously reported (2).  Basal  PIP2 
levels were then measured in each subset (Fig. 1B). In addition, 
we determined the kinetics of BCR-induced PIP2 production in 
each B cell subpopulation following stimulation with 20 μg/ml 
anti-IgM F(ab’)2 antibodies. In all splenic B cell subsets, PIP2 
levels were reduced immediately in response to stimulation with 
anti-IgM, indicative of PIP2 hydrolysis (Fig. 1C).
Optimal lipid labeling with [3H]palmitic acid is achieved 
in 6 hours
To  analyze  the  lipid  synthesis  and  BCR-directed  DAG 
production  in  wild  type  primary  B  cells,  we  systematically 
assessed  the  numbers  of  primary  B  cells  and  the  amount  of 
radioactivity  required  for  optimum  labeling. MACS-enriched 
total splenic B cells or FACS-sorted B cell subsets were used 
immediately for labeling with [3H]palmitic acid, a saturated fatty 
acid (6). Pilot experiments indicate that optimal lipid synthesis 
is  achieved  with  a  concentration  of  2.5  mCi/ml  (data  not 
shown).  Using  this  information,  we  discovered  that  the 
incorporation  of  radioactivity  was  detectable  after  30  min, 
increased in a time-dependent manner reaching a plateau at 6 h, 
and remained unchanged  through 24 h (  Fig.  2A).  The  same 
profile was obtained when the results were expressed as cpm/mg 
protein indicating a dynamic process (data not shown). 
BCR-induced DAG production is dose-dependent and can 
be detected with as few as 0.5x106 B cells
MACS-enriched  total  B  cells  were  labeled  for  6  h  with 
[3H]palmitic  acid,  then  were  stimulated  for  5  minutes  with 
various  concentration  of  anti-IgM  antibodies  in  order  to 
determine  the  production  of  DAG  (12).  DAG  production 
increases in a dose dependent manner and is optimal at 20 μg/ml 
of anti-IgM (Fab’)2 (Fig. 2B).
To test the feasibility of DAG quantification experiments with 
small numbers of primary B cells, we labeled MACS-enriched 
total B cells for 6 h with [3H]palmitic acid, and  determined its 
incorporation into whole lipids in various numbers of B cells. 
We observed a strong correlation between the total radioactivity 
detected in whole lipids with the number of B cells labeled (r = 
0.998). It is noteworthy that the radioactivity was close to 50000 
and 100000 cpm for 0.5x106 and 1x106 labeled cells respectively 
(Fig. 2C). Since the level of DAG represents 0.6% of total lipids 
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Fig.  1A & 1B: PIP2 is  hydrolyzed in  all  B  cell  subsets 
following anti-IgM stimulation. (A) : Freshly isolated MACS-
enriched  wt  B  cells  were  fixed  with  2%  paraformaldehyde, 
permeabilized  and  labeled  with  antibodies  directed  against 
CD19, CD21, and HSA for B cell subset identification.  (B):   B 
cells from (A) were examined for basal PIP2 levels utilizing an 
anti-PI(4,5)P2 antibody.  Data  is  an  example  of  multiple 
experiments.
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extracted  from  the  mouse  primary  splenic  B  cells  (2),  the 
amount of [3H]DAG in 0.5x106 B cells should be close to 500 
cpm which is more than 100 times greater than the background, 
and  should  therefore  allow  reliable  estimation  of  DAG 
production. 
We next determined the level of BCR-induced DAG production 
after 5 minutes of stimulation with anti-IgM (20 μg/ml) using 
various numbers of  MACS-enriched total  B cells  ranging from 
0.5x106 to 5x106. The results show that upon BCR ligation the 
profile  of  DAG  production  obtained  from  a  small  number 
(0.5x106)  of  primary  B  cells  coincides  precisely  with  that 
obtained  from  a  large  number  (5x106)  of  B  cells  (Fig.  2D). 
When 0.5x106 B cells were labeled with [3H]palmitic acid, the 
radioactivity  detected  in  DAG was  similar  to  that  calculated 
from the standard curve (450 cpm corresponds to 0.5% of total 
lipids). Therefore, lipid signaling in transitional B cell subsets 
may be investigated using [3H]palmitic acid as the radioactive 
labeling precursor.  In  this regard,  we previously demonstrated 
that BCR-mediated DAG production occurs in T2 and mature B 
cells following both 5 min (2.1- ± 0.1-fold increase, and 5.1-  ± 
0.3-fold  increase,  respectively,  compared  with  the  non-
stimulated control)  and 30 min (2.8-  ± 0.3-fold increase,  and 
4.8- ± 0.4-fold increase,  respectively,  compared with the non-
stimulated control) stimulation with anti-IgM (2). In contrast, T1 
B  cells  did  not  produce  DAG  in  response  to  anti-IgM 
stimulation (2).
HPLC analysis of BCR-induced IP3 production in splenic B 
cell subsets 
Because we observed significant differences in BCR-mediated 
DAG  production  in  transitional  B  cell  subsets,  we  also 
investigated  the  production  of  IP3 in  response  to  BCR 
stimulation utilizing HPLC. Using MACS-enriched total B cells, 
we first performed a kinetics study and determined that 1 minute 
of  anti-IgM  stimulation  was  the  optimum  time-point  for  IP3 
detection  (Figure  3A and  B).  We then  utilized  1x106 FACS-
purified  transitional  T1  and  T2  B  cells  to  investigate  IP3 
production following anti-IgM stimulation. T2 B cells produced 
significantly more IP3 than T1 B cells (1.52 ± 0.5-fold increase 
and 3.09 ± 0.2-fold increase, respectively; n = 3) (Figure 3 C-E), 
consistent with the previously observed DAG production profile 
(2). 
FCM analysis of intracellular Ca2+ mobilization in B cell 
subsets 
Because  the  generation  of  IP3 subsequently  induces  Ca2+ 
mobilization  in  primary  wt B  cells  (15),  we  next  wanted  to 
investigate calcium mobilization in B cell subsets. To precisely 
define stage-specific calcium mobilization within B cell subsets, 
we  utilized  FCM  techniques.  1x106 MACS-enriched  B  cells 
were loaded with indo-1-AM and labeled with a combination of 
anti-C1qRp (AA4.1), anti-HSA and anti-CD23 antibodies for B 
cell subset identification (Fig. 4A). Antibodies directed against 
B220,  CD19,  and  CD21  were  not  used  in  order  to  avoid 
inadvertent  B  cell  activation.  Cells  were  applied  to  the 
cytometer, baseline measurements taken for 60-90 seconds, then 
stimulated with anti-IgM for the indicated times. From the AA4+ 
gate, T1 (HSAhiCD23-) and T2 (HSAhiCD23+) cells were gated 
for calcium analysis. The vast majority of T2-preMZ cells do 
not express AA4.1; therefore they are excluded from T2 cells 
gated  in  this  manner.  From  the  AA4-  gate,  mature  FoB 
(HSAloCD23+) and MZ (HSAmidCD23lo) were gated for calcium 
analysis. Our results demonstrate that calcium mobilization can 
be  monitored  in  all  B  cell  subsets  following  anti-IgM 
stimulation,  using  as  few  as  1x106 MACS-enriched,  FACS-
stained total B cells (Fig. 4B).
DISCUSSION
The  goal  of  this  study  was  to  develop  protocols  to  assess 
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Fig.  1C  & 1D:  PIP2 is  hydrolyzed  in  all  B  cell  subsets 
following anti-IgM stimulation. (C): B cells were stimulated 
for  the  indicated  times  with  20  μg/ml  anti-IgM,  immediately 
fixed  and  permeabilized,  then labeled  and  examined for  PIP2 
levels as in (B); T1 (filled diamonds), T2 (filled squares), mature 
FoB (open circles), preMZ (filled triangles), mature MZB (open 
triangles).  Data is  displayed as  the average MFI  of  duplicate 
samples, and is a representative of at least 4 experiments. (D): 
The  specificity  of  the  anti-PIP2 antibody  was  tested  by  pre-
incubation of the antibody with PIP2 liposomes for 15 min prior 
to intracellular labeling of MACS-enriched total B cells as in (B). 
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dynamic  changes  in  lipid  signaling  in  each  B  cell  subset 
following antigenic stimulation. By utilizing FCM techniques to 
assess both PIP2 levels and calcium mobilization in individual B 
cell subsets,  we eliminated the necessity for purification of B 
cell subsets in these analyses. Additionally, we defined optimal 
conditions to rapidly analyze DAG and IP3 production utilizing 
numbers  of  total  primary B  cells  similar  to  the  quantities  of 
transitional B cells that can be obtained by magnetic bead and 
FCM based cell sorting protocols (2, 16).
In this report we used a combination of the most current staining 
schemes to identify B cell subpopulations in the spleen by FCM 
(1-4, 16, 17). We have combined extracellular staining for B cell 
subset  identification  with  intracellular  staining  protocols  in 
order  to determine PIP2 levels in all  B cell  subsets following 
stimulation with anti-IgM (Fig. 1). It  is important to note that 
following  an  initial  period  of  BCR-induced  PIP2 hydrolysis, 
BCR-induced  PIP2 production  occurs  in  all  the  B  cell 
subpopulations (Fig. 1C). This increase in PIP2 over time may 
result  from  DAG  conversion  into  PIP2 or  PIP2 synthesis  by 
PIP5K following BCR stimulation (18, 19). Thus, a PIP2 cycle is 
activated in B cells in response to BCR cross-linking. The lower 
production  of  DAG  and  IP3 in  T1  B  cells  suggests 
developmental  stage-specific  mechanisms  of  PIP2 cycling  in 
splenic B cell subpopulations. Additionally, it is noteworthy that 
the B cell subset with the lowest baseline (mature FoB) had the 
greatest changes in PIP2 MFI while the B cell subsets with the 
highest baselines (T2 and preMZ) had the smallest changes in 
PIP2 MFI (Fig. 1C), indicating that the inducible production of 
PIP2 through BCR stimulation is tightly associated with its basal 
level.  As we have previously shown for PKC phosphorylation 
(2),  this protocol  can be extended to  study other  intracellular 
biochemical signaling events following antigenic stimulation.
In  addition,  we  have  employed  FCM techniques  in  order  to 
assess calcium mobilization in B cell subsets. Again, employing 
a  unique  combination  of  antibodies,  which  identify  B  cell 
subsets but will not activate cells inadvertently,  we monitored 
calcium mobilization in each B cell subset following antigenic 
stimulation using as few as 1x106 MACS-enriched B cells and 
found that all  B cell subsets mobilize calcium following anti-
IgM stimulation (Fig. 4). These FCM-based techniques use only 
minimal numbers of primary B cells, and eliminate the need for 
FACS-based cell sorting of individual B cell populations.
We also report that  3[H]palmitic acid can be used to efficiently 
label lipids in primary splenic B cells. We observed that peak 
radioactivity is  reached after 6 h of labeling (Fig.  2A).  Since 
splenic  B  cells  die  rapidly  in  vitro in  the  absence  of  B  cell 
growth factors and/or agonists, the relatively short duration of 
labeling (6 h) with  3[H]palmitic acid minimizes the loss of B 
cells  (16,  17).  Our  results  also show that  lipid levels  can  be 
determined  with  small  numbers  of  B  cells,  and  that  the 
radioactivity incorporated into lipids in 0.5x106 B cells is close 
to 5x104 cpm (8000 times higher than the background) which 
should  allow  easy  quantification  of  lipid  species  (Fig.  2C). 
These  data  are  in  agreement  with  studies  performed  with 
primary B cells labeled with [3H]arachidonic acid (15), both in 
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Fig.  2:  Lipid  synthesis  and  DAG  production  in  small 
numbers of primary B cells. (A): Kinetics of lipid synthesis in 
primary B cells. Incorporation of [3H]palmitic acid (2.5 mCi/ml) 
into lipids was determined in purified wt primary B cells. Lipid 
extraction was performed according the protocol of Folch (10). 
Lipid synthesis is expressed in cpm and represents the average 
+ SEM of three independent performed in triplicate.  (B): BCR-
induced DAG production is  dose  dependent.  5x106 purified  B 
cells were labeled for 6h with [3H]palmitic acid (2.5 mCi/ml) and 
stimulated for 5 min with various doses of anti-IgM. Lipids were 
extracted  and  separated  as  described  (12)  and  DAG  was 
quantified. DAG is expressed as percentage increase of DAG of 
total radioactivity and represents the average + SEM of three 
independent performed in triplicate. *P<0.05; ***P<0.001.  (C): 
[3H]palmitic  acid  is  incorporated  into  whole  lipids  in  small 
numbers  of  primary  B  cells.  The  indicated  numbers  of  non-
stimulated  B  cells  from  wt  mice  were  labeled  for  6h  with 
[3H]palmitic  acid  (2.5  mCi/ml)  and  total  incorporation  of 
[3H]palmitic  acid  into  lipids  (r=0.998)  was  monitored  as 
described  (6).  (D): BCR-induced  DAG  production  can  be 
measured  in  as  few  as  0.5x106 primary  B  cells.  The  same 
protocol as in (B) was applied to 0.5-5x106 primary B cells that 
were  stimulated  for  5  minutes  with  20  μg/ml  of  anti-IgM. 
***P<0.001.
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the  profile  of  DAG  accumulation  and  the  quantity  of 
radioactivity.
An alternate enzymatic method for the quantification of DAG 
employed an Escherichia coli DAG kinase which catalyzes the 
production of [32P]phosphatidic acid from DAG substrate (20). 
This radiosensitive assay was successfully developed for sn-1,2 
diacylglycerols quantification. Moreover, the DAG kinase assay 
was  already  applied  to  Epstein-Barr  virus  negative  Burkitt's 
lymphoma Ramos  cells  to  quantify  ceramide  (21).  Here,  our 
lipid  separation  method  allows  the  separation  of  sn-1,2 
diacylglycerol from sn-1,3 diacylglycerol species, and the DAG 
level reflects that of both isomers (12). In addition, we were able 
to  quantify  other  neutral  lipid  species  (palmitic  acid, 
mLtriglycerides, and monoglycerides) in one single experiment 
(data not shown).
Development of immunocompetent B-lymphocytes is critically 
dependent on signaling through the BCR (5). Our results show 
that  while  20  μg/ml  of  anti-IgM  (Fab’)2 antibodies  induces 
maximal  production  of  DAG,  lower  doses  also  lead  to 
significant production of DAG (Fig. 2B).
We also demonstrate that in response to BCR cross-linking, an 
increase in DAG production is clearly detectable with as few as 
0.5x106 B cells  (Fig.  2D).  We have  previously employed  the 
methods described in this report to determine DAG production 
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Fig.  3A & 3B:  Generation of  IP3  in  primary B cells: A) 
Timecourse of IP3 production in primary B cells.  3x10
6 MACS-
enriched B cells were labeled with 3[H]inositol (60 mCi/ml) for 4 
h, then incubated with PBS (non-stimulated) or stimulated with 
20 μg/ml anti-IgM for the indicated times. Production of soluble 
IP  species  was  measured  by  HPLC  and  the  position 
corresponding to each species is indicated. IP3 production was 
measured as the total counts detected within the 14.25-15.25 
minute time window. HPLC profile  of  an  ipk1-5 mutant yeast 
strain (26) serves as reference.  (B):  IP3 production from the B 
cells  in  (A)  is  expressed  as  the  counts  in  the  position 
corresponding to IP3.
Fig. 3C – 3E:  Generation of IP3 in primary B cells: (C): 
1x106 FACS-purified  wt T1  and  T2  B  cells  were  labeled  with 
3[H]inositol as in (A) and stimulated with 20 μg/ml anti-IgM for 1 
minute.  IP3 production  was  detected  as  in  (A).  Data  is  a 
representative  of  four  independent  experiments.  (D):  IP3 
production from the T1 and T2 B cells in (C) is expressed as the 
counts in the position corresponding to IP3. E) Fold change in IP3 
level from T1 and T2 B cells following stimulation with anti-IgM 
was  calculated  from  the  counts  measured  in  the  position 
corresponding to IP3 as in (C and D) (n=3).
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following anti-IgM stimulation in 1x106 FACS-purified T1, T2 
and mature FoB cells (2). In that study, we reported that T2 and 
FoB cells rapidly produce detectible levels of DAG following 
anti-IgM  stimulation  and  that  increased  DAG  levels  are 
maintained for a significant period of time, while T1 B cells do 
not  produce  DAG  at  any  time-point  following  anti-IgM 
stimulation (2).
After  we  observed  that  DAG  was  differentially  produced  in 
transitional  B  cells  subsets,  we  wanted  to  confirm  that  IP3 
production followed a similar  pattern,  as  these two lipids are 
both  by-products  of  PIP2 hydrolysis.  Consistent  with  DAG 
production, IP3 was detected by HPLC in total B cells and in 
purified T2 B cells, but not in purified T1 B cells (Fig. 3 A and 
C). In addition to IP3, we found that levels of other IPs (i.e., IP1, 
IP2, IP4, and IP5) also change in all B cell populations, however, 
these changes are most apparent in total B cells (Fig. 3A). This 
observation  may  reflect  more  robust  changes  in  mature 
follicular  B  cells,  which  is  the  predominant  population 
(approximately 60-70%) in splenic B cells. Thus, the magnitude 
of BCR-induced IP3 production is likely to be underestimated 
because IP3 can undergo additional phosphorylations by kinases 
to generate IP4, IP5 IP6. These findings also raise the possibility 
that other IPs may also play distinct roles in modulating B cell 
physiology.  Indeed,  a  previous  report  showed  that  the  PH 
domain of Btk functions as an inositol 1,3,4,5-tetrakisphosphate 
(IP4),  inositol  1,3,4,5,6-pentakisphosphate  (IP5),  and  inositol 
1,2,3,4,5,6-hexakisphosphate (IP6) binding domain and that  xid 
mutations  (R28C)  found  in  the  Pleckstrin  Homology domain 
result  in  a  dramatic  reduction  of  IP4 binding  activity  (22). 
Consistent with these results, BCR-induced DAG/IP3 production 
is Btk dependent, suggesting that B cell differentiation is likely 
to be correlated with the IP4 binding capacity of the PH domain 
of Btk (2,  22,  23).  Additionally,  a recent report  revealed that 
inositol 1,4,5-triphosphate 3-kinase and its reaction product IP4 
are both required to mediate survival signalling in B cells via a 
Ras-ERK signalling pathway that controls the expression of the 
proapoptotic protein, Bim (24).
Together,  these  results  demonstrate  our  ability  to  perform 
experiments  to  determine  BCR-dependent  lipid  signaling 
utilizing the small numbers of B cells that are obtained with any 
of  the  B  cell  subpopulation  purification  protocols  we  have 
previously published (2, 16). Additionally, while these protocols 
were established in cells that were stimulated through the BCR, 
it  is  reasonable  to  believe that  these  protocols  will  be  useful 
when monitoring B cell  activation by many different  cellular 
stimuli;  in  fact,  we  have  already  utilized  these  protocols  to 
monitor  DAG  and  IP3 production,  as  well  as  calcium 
mobilization, in B cells stimulated with BAFF (25). Thus, the 
protocols  that  we  describe  in  this  report  should  allow  a 
comprehensive determination of differential lipid signaling and 
signal transduction in primary B cell populations in response to 
various stimuli.
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B cell purification by negative selection
Materials: 
FACS buffer (PBS + 2% FBS)
MACS buffer (PBS + 0.5% BSA and 1mM EDTA)
Complete RPMI (RPMI + 10% FBS, 4mM L-glut, 100U P/S, 0.1% 2-ME, 10mM HEPES)
* anti-mouse CD43 magnetic beads (130-049-801 Miltenyi Biotech)
* AutoMACS automated cell sorter or MiniMACS columns (Miltenyi Biotech)
** B-cell enrichment kit (557792 BD Biosciences) and manual IMAG magnet 
1) Harvest the spleen from a wt C57BL/6 mouse.
2) Isolate splenocytes by smashing spleen in a 70 mM cell strainer with 5ml PBS. Transfer cells to a 15ml conical tube and 
rinse strainer 2X with 5ml PBS. Transfer washes to the tube with cells and centrifuge for 6 minutes at 1600 rpm at 4°C.
3) Aspirate  supernatant  and  lyse  RBC,  while  vortexing,  by  the  addition  of  900  μL sterile  filtered  ddH20  followed 
immediately by the addition of 100 μL 10x PBS. Remove floating fat, and add FACS buffer to 10 ml.
4) Count cells.
5) Centrifuge cells for 6 minutes at 1600 rpm at 4°C. Resuspend cells at 100x106/ml in MACS buffer.
6) *Add anti-CD43 beads and incubate according to the manufacturers instructions.
7) *Sort  cells  on  the  AutoMACS using the  DelpeteS  cycle  or  on  the  MiniMACS magnetic  columns  according to  the 
manufacturers directions.
8) Resuspend CD43-negative cells in 1-2 ml of complete RPMI and count cells. 
9) Stain a small aliquot for purity with anti-B220 or anti-CD19, and analyze by FCM.
** 6-7)  Alternatively, B cells can be enriched using the B cell enrichment kit and manual magnet from BD according to 
the manufaturers instructions.
PIP2 quantitation by FCM
Materials: 
Stop buffer (PBS + 2% paraformaldehyde)
BD Cytofix/Cytoperm kit
Fix buffer (FACS + 2% paraformaldehyde)
*Biotinylated anti-PIP2 antibody (Z-B045; Echelon Biosciences)
Anti-HSA-FITC antibody (BD clone M1/69)
Anti-CD21-PE antibody (BD clone 7G6)
*SAv-PerCP-Cy5.5 (BD 551419) 
Anti-CD19-APC antibody (BD clone 1D3)
*anti-PIP2-FITC (Z-G045; Echelon Biosciences)
1) Resuspend MACS-enriched B cells in RPMI (10x106/ml) and rest on ice for 1hr.
2) Warm cells in a 37°C water bath for 15 minutes
3) Prepare “Stop” tubes (1ml stop buffer) for each time point
4) Harvest Time 0 sample by collecting 100 μl (1x106 cells) into the appropriate stop tube (harvest an extra sample if staining 
with an isotype control)
5) Stimulate cells for desired time with anti-IgM F(ab’)2
6) Harvest cells by collecting 100 μl at each desired time point into appropriate stop tubes
7) Centrifuge 1700 rpm for 4 minutes
8) Fix/permeabilize using BD Cytofix/cytoperm kit according to manufacturer’s instructions
9) *Intracellular stain with anti-PIP2-biotin (1:500) in 100 μl perm-wash buffer/1x106 cells for 20 minutes. Wash with 1ml 
perm-wash, and spin at 1700 rpm for 4 minutes.
10) *Stain intracellular with SAv-PerCP-Cy5.5 (1:300), and extracellular with anti-HSA (1:500), anti-CD21 (1:250),  and 
anti-CD19 (1:100) in 100 μl perm-wash buffer/1x106 cells for 20 minutes. Wash with 1ml perm-wash, and spin at 1700 
rpm for 4 minutes.
11) Resuspend cells in 100μL FACS + 100 ml Fix.
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12) Acquire data on FACS machine.
** 9-10) Alternatively, anti-PIP2-FITC (1:300) can be used to study PIP2 levels in total B cells (for subset identification, 
use in combination with HSA-PE (1:500), CD19-PerCP-Cy5.5 (1:200), and CD21-APC (1:400); all from BD)
DAG quantification by TLC
1) Resuspend purified B cells in complete RPMI, and label cells with 2.5 mCi/ml [3H]palmitic acid (Sigma) for 6 hours at 
37°C, 5% CO2.
2) Spin cells at 2000 rpm for 5 minutes.
3) Remove supernatant
4) Wash cells twice with RPMI without serum 
5) Resuspend cells (3x106/ml) in PBS in glass tubes and warm to 37°C .
6) Incubate cells with 20 μg/ml anti-IgM F(ab’)2 for appropriate times at 37°C.
7) Stop reactions by adding 1 ml cold PBS
8) Spin the cells at 3000 rpm for 5 minutes and wash twice with PBS
9) Remove supernatant
10) Extract lipids with 2 ml of a mixture of cold chloroform:methanol (2:1, v:v)
11) Place the samples at 4 °C overnight
12) Add 400 μl HCl (0.5N) to the 2 ml sample
13) Vortex tubes for 10 seconds
14) Spin at 3000 rpm for 5 minutes at 4°C 
15) Take 10 μl of the upper phase and count the radioactivity in scintillation counter to ensure that after washing the cells no 
radioactivity  remains  in  the  aqueous  phase.  Presence  of  radioactivity  in  the  aqueous  phase  will  indicate  poor  lipid 
labelling and the experiment should be discarded.
16) Remove the upper phase
17) Transfer 1 ml of the organic phase to a new glass tube
18) Remove 10 μl of the organic phase and count the radioactivity in scintillation counter
19) Add 40 μl of cold carrier lipids (mixture of phosphatidic acid, monoglycerides, 1-2 dipalmitin, palmitic acid, tripalmitin, 
each at 10 mg/ml; Sigma)
20) Evaporate the organic phase gently under an N2 stream
21) Resuspend the residue in 40 μl chloroform-methanol (2:1, v:v)
22) Load on a 20x20 cm Silica Gel plate (Merck)
23) Separate neutral lipids from the other lipids in the upper phase with a mixture of ethylacetate:isooctane:acetic acid:water 
(130:20:30:100)
24) Allow the TLC to run half-way on the plate (25-30 minutes) in the first dimension
25) Dry the plate gently with a hair dryer for 10 minutes
26) Further separate the neutral lipids with a mixture of isopropylether:acetic acid (96:4, v:v) in the second dimension
27) Dry the plates gently with a hair dryer for 10 minutes
28) Spray the plates with primulin (in acetone-water 8:2, v:v)
29) Using the carrier lipids as markers, identify the lipid species, and scrape the desired lipids (in silica) into scintillation vials
30) Add 150 μl of water and 3 ml of scintillation fluid
31) Vortex each tube for 20 seconds 
32) Count radioactivity 
IP3 quantification by HPLC
Soluble Inositol Polyphosphate (IP) Extraction
1) Incubate MACS-enriched total B cells or FACS-purified B cell subsets (10x106/ml) in inositol-free DMEM containing 60 
mCi [3H]Inositol/ml (Perkin Elmer) for 4 hours. 
2) Harvest cells, wash twice with 1 ml PBS and suspended in PBS (10x106/ml) in a glass tube.
3) Dispense 100 μl aliquots (1x106 cells) in 2.0 ml screw-cap polypropylene tubes.
4) Warm cells to 37°C for 5 min.  Treat cells with 25 μl PBS with or without 20 μg/ml goat anti-mouse IgM F(ab’)2 for 
desired time.
5) Stop treatments by adding 6.6 μl 10 N HCl and chilling cells instantly on ice. 
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6) Extract  soluble IPs by adding 465 μl of chloroform/methanol (1:2 v/v).  Vortex the mixture at  maximum speed for 2 
minutes. 
7) Add 156 μl each of chloroform and 2 M KCl and vortex for another 2 minutes. 
8) Spin the lysate at 13,000 g for 5 minutes and the collect the supernatant in a screw-cap tube. Store at -20°C if needed.
Separation of IPs through HPLC
Analyze the samples by the HPLC (Shimadzu Corporation) connected to the Radio-HPLC Detector (IN/US Systems, Inc.). 
Sample preparation: Add ammonium phosphate (pH 3.5) to the supernatant (10 mM final). Filter through an Amicon Ultrafree-MC 
0.45 mm filter unit (Millipore). 
HPLC: Inject sample (500 ml) onto a Whatman partisphere SAX strong-anion exchange column (4.6 x 125 mm). Resolve the IPs 
by a linear  gradient  from 10 mM to 1.7 M ammonium phosphate (pH 3.5) for 25 minutes,  followed by elution with 1.7 M 
ammonium  phosphate  for  20  minutes.  For  detection  by  an  online  Radio-HPLC  detector,  use  Tru-Count  (IN/US  System) 
scintillation counting solution in 1:1 ratio. 
Calcium mobilization by FCM
Materials needed:
HBSS w/o phenol red (containing 10% FCS, 1mM Mg++, with/without 1mM Ca++)
Indo-1-AM (Molecular probes I-1223), resuspended at 1 mg/ml in DMSO
Anti-HSA-PE antibody (BD clone M1/69) 
Anti-CD23-biotinylated antibody (BD clone B3B4)
AA4.1-APC (e-bioscience 17-5892)
Non-indo-labeled cells to use for single stain controls for FCM
1) Rest MACS-enriched B cells on ice in complete RPMI for 1-2hrs
2) Wash cells, resuspend (10x106 cells/ml) in warm HBSS (without calcium), and load with indo-1-AM  (5μg/ml) for 30 
minutes in a humidified 37°C incubator.
3) Wash cells twice with HBSS 
4) Suspend cells (20x106 cells/ml) in FACS, and place on ice (reserve a small aliquot of indo-labeled cells to serve as the 
indo-1 single stain control for FCM)
5) Label remaining cells with biotinylated-CD23 (1:200 dilution) for 20 minutes (label single stain control cells as well)
6) Wash cells, and suspend (20x106 cells/ml) in FACS 
7) Label cells  with HSA-PE (1:750 dilution),  SAv-PerCP-Cy5.5 (1:200 dilution),  and AA4-APC (1:100 dilution) for 20 
minutes (label single stain control cells as well)
8) Wash cells, and suspend (1x106 cells/ml) in HBSS (with calcium)
9) Keep on ice until assay
10) Warm cells for 15 minutes in a 37°C water bath prior to assay
11) Compensate the flow cytometer with single stain control cells
12) Load sample onto flow cytometer set to measure the ratio of Indo-1-violet/Indo-1-blue
13) Take baseline (non-stimulated) measurement for 30-90 seconds
14) Stimulate cells, and measure calcium ratio for 4-10 minutes
** To monitor  calcium efflux  from the ER without  influx  of  extracellular  calcium, use  calcium-free  HBSS when acquiring. 
Calcium can be added back in to monitor calcium influx.
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